Previous Close | 0.6000 |
Open | 0.5700 |
Bid | 0.5600 x 1000 |
Ask | 0.6000 x 3200 |
Day's Range | 0.5793 - 0.5793 |
52 Week Range | 0.3650 - 6.3000 |
Volume | |
Avg. Volume | 46,606 |
Market Cap | 17.694M |
Beta (5Y Monthly) | 1.45 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2640 |
Earnings Date | Mar 22, 2022 - Mar 28, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.11 |
Liminal BioSciences Inc. (LMNL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today reported its financial results for the first quarter ended March 31, 2022.
Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021. Liminal will host a conference call and webcast to discuss financial results at 8:30 am (ET) on Wednesday May 11, 2022.